ID   DLD-1 AKT2(-/-)
AC   CVCL_HD53
SY   AKT2 (-/-) DLD-1
DR   Horizon_Discovery; HD+R00-002
DR   Wikidata; Q54831150
RX   PubMed=20133737;
RX   PubMed=27878243;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; 392; AKT2.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 5
//
RX   PubMed=20133737; DOI=10.1073/pnas.0914018107;
RA   Ericson K., Gan C., Cheong I., Rago C., Samuels Y., Velculescu V.E.,
RA   Kinzler K.W., Huso D.L., Vogelstein B., Papadopoulos N.;
RT   "Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal
RT   cancer cells clarifies their roles in tumor growth regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2598-2603(2010).
//
RX   PubMed=27878243; DOI=10.3892/ijo.2016.3771;
RA   Haggblad Sahlberg S., Mortensen A.C., Haglof J., Engskog M.K.R.,
RA   Arvidsson T., Pettersson C., Glimelius B., Stenerlow B., Nestor M.;
RT   "Different functions of AKT1 and AKT2 in molecular pathways, cell
RT   migration and metabolism in colon cancer cells.";
RL   Int. J. Oncol. 50:5-14(2017).
//